Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

Leukemia

Volumn 26, Issue 9, 2012, Pages 2154-2158

  Yip, B H ^a   Pellagatti, A ^a   Vuppusetty, C ^a   Giagounidis, A ^b   Germing, U ^c   Lamikanra, A A ^a   Roberts, D J ^a   Fernandez Mercado, M ^a   McDonald, E J ^d   Killick, S ^d   Wainscoat, J S ^a   Boultwood, J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ST JOHANNES HOSPITAL   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD71 ANTIGEN; LEUCINE; PROTEIN P21; PROTEIN P53; RIBOSOME PROTEIN; RPS14 PROTEIN; UNCLASSIFIED DRUG;

5Q- SYNDROME; APOPTOSIS; BIOGENESIS; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROPOIESIS; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; UPREGULATION;

ANEMIA, MACROCYTIC; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; CRI-DU-CHAT SYNDROME; ERYTHROBLASTS; FLOW CYTOMETRY; HUMANS; LEUCINE; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRISOMY;

EID: 84865860916     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.82     Document Type: Letter

References (15)

1. Boultwood J, Fidler C, Strickson AJ, Watkins F, Gama S, Kearney L et al. Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome. Blood 2002; 99: 4638-4641. (Pubitemid 34627240)
2. Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L et al. Gene expression profiling of CD34 + cells in patients with the 5q-syndrome. Br J Haematol 2007; 139: 578-589. (Pubitemid 350043812)
3. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008; 451: 335-339.
4. Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat Med 2010; 16: 59-66.
5. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011; 117: 2567-2576.
6. Pellagatti A, Hellstrom-Lindberg E, Giagounidis A, Perry J, Malcovati L, Della Porta MG et al. Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genes. Br J Haematol 2008; 142: 57-64. (Pubitemid 351783162)
7. Pellagatti A, Jadersten M, Forsblom AM, Cattan H, Christensson B, Emanuelsson EK et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients. Proc Natl Acad Sci USA 2007; 104: 11406-11411. (Pubitemid 47175153)
8. Gazda HT, Kho AT, Sanoudou D, Zaucha JM, Kohane IS, Sieff CA et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 2006; 24: 2034-2044. (Pubitemid 44477128)
9. Cmejlova J, Dolezalova L, Pospisilova D, Petrtylova K, Petrak J, Cmejla R. Translational efficiency in patients with Diamond-Blackfan anemia. Haematologica 2006; 91: 1456-1464. (Pubitemid 44736111)
10. Pospisilova D, Cmejlova J, Hak J, Adam T, Cmejla R. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007; 92: e66-e67.
11. Jaako P, Debnath S, Olsson K, Flygare J, Karlsson S. Bone marrow failure in RPS19-deficient mice is partly caused by p53 activation and responds to L-Leucine treatment. Blood 2011; 118: 727.
12. Virgilio M, Payne E, Narla A, Sun H, Paw B, Look AT et al. Treatment of zebrafish models of ribosomopathies (Diamond Blackfan Anemia (DBA) and 5q-Syndrome) with L-leucine results in an improvement of anemia and developmental defects: evidence for a common pathway? Blood 2010; 116: 195.
13. Kimball SR, Jefferson LS. New functions for amino acids: effects on gene transcription and translation. Am J Clin Nutr 2006; 83: 500S-507S. (Pubitemid 44713227)
14. Sen S, Wang H, Nghiem CL, Zhou K, Yau J, Tailor CS et al. The ribosomerelated protein, SBDS, is critical for normal erythropoiesis. Blood 2011; 118: 6407-6417.
15. List A, Dewald G, Bennett J, Giagounidis A, Raza A, Feldman E et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 2006; 355: 1456-1465. (Pubitemid 44511560)